Basso Capital Management’s New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at NFC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-154,944
Closed -$155K 286
2019
Q3
$155K Sell
154,944
-67,400
-30% -$70.7K 0.03% 159
2019
Q2
$156K Buy
222,344
+209,247
+1,598% +$145K 0.03% 144
2019
Q1
$9K Sell
13,097
-703
-5% -$529 ﹤0.01% 181
2018
Q4
$12K Sell
13,800
-75,000
-84% -$80.1K ﹤0.01% 170
2018
Q3
$105K Buy
+88,800
New +$105K 0.02% 121

Other funds holding NFC.WS

Basso Capital Management's NFC.WS Position: Q4 2019 in Review

Basso Capital Management sold out of New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at (NFC.WS) in Q4 2019, closing a stake of 154,944 shares — an estimated $155K sold.

Basso Capital Management first reported a position in NFC.WS in Q3 2018 and held it in 5 quarters. The position peaked at $156K in Q2 2019. 1 fund tracked by Wall St. Rank holds NFC.WS as of Q4 2019.

  • Basso Capital Management reported no remaining New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at position as of Q4 2019 after selling out during the quarter.
  • Basso Capital Management sold 154,944 New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at shares in Q4 2019, an estimated $155K.
  • Basso Capital Management first reported a position in New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at in Q3 2018 and held it in 5 quarters.
  • Basso Capital Management's New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at position peaked at $156K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at as of Q4 2019.

Based on Basso Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.